B

Baylor Scott and White Health | Soltero Cardiovascular Research Center

Research site
(Unclaimed)
Location
621 N Hall Street, Ste 530, Dallas, Texas, United States of America
Site insights

Top conditions

Heart Failure (3 trials)

Myocardial Ischemia (1 trial)

Hepatitis (1 trial)

Sclerosis (1 trial)

Multiple Sclerosis (1 trial)

Top treatments

sodium
EMPagliflozin
Daratumumab
Evolocumab
Apixaban
DUR-928
Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlus...

Active, not recruiting
Venous Occlusion
Venous Stenosis
Device: PTA
Device: Merit WRAPSODY Endovascular Stent Graft

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems